Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

johnson-announces-retirement-after-being-part-of-fox’s-nfl-coverage-for-31-years

Johnson announces retirement after being part of Fox’s NFL coverage for 31 years

Mar 3, 2025

Jimmy Johnson has announced his retirement from Fox Sports after being a part of its NFL coverage for…

Read more
investors-should-be-wary-of-analyst-ratings

Investors should be wary of analyst ratings

Mar 3, 2025

Explore more offers. Standard Digital Essential digital access to quality FT journalism on any device. Pay a year…

Read more
analyst-estimates:-here’s-what-brokers-think-of-mirum-pharmaceuticals,-inc.-(nasdaq:mirm)-after-its-full-year-report

Analyst Estimates: Here’s What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report

Mar 3, 2025

Last week, you might have seen that Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) released its yearly result to the market.…

Read more
gabungan-aqrs-berhad-(klse:gbgaqrs)-analysts-just-trimmed-their-revenue-forecasts-by-15%

Gabungan AQRS Berhad (KLSE:GBGAQRS) Analysts Just Trimmed Their Revenue Forecasts By 15%

Mar 2, 2025

The latest analyst coverage could presage a bad day for Gabungan AQRS Berhad (KLSE:GBGAQRS), with the analysts making…

Read more
psychedelic:-gh-research,-compass-pathways-report-earnings-results

Psychedelic: GH Research, Compass Pathways report earnings results

Mar 2, 2025

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now TipRanks Fri, Feb 28, 2025,…

Read more
analyst-estimates:-here’s-what-brokers-think-of-ambarella,-inc.-(nasdaq:amba)-after-its-yearly-report

Analyst Estimates: Here’s What Brokers Think Of Ambarella, Inc. (NASDAQ:AMBA) After Its Yearly Report

Mar 1, 2025

Ambarella, Inc. (NASDAQ:AMBA) defied analyst predictions to release its annual results, which were ahead of market expectations. Ambarella…

Read more
this-costar-group-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-friday-–-avalo-therapeutics-(nasdaq:avtx),-altimmune-(nasdaq:alt)

This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday – Avalo Therapeutics (NASDAQ:AVTX), Altimmune (NASDAQ:ALT)

Feb 28, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
top-analyst-coverage-updates:-(aapl)-(nvda)-(ebay)

Top Analyst Coverage Updates: (AAPL) (NVDA) (EBAY)

Feb 28, 2025

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail…

Read more
nvda-stock-rallies-alongside-analyst-updates-after-q4-beats

NVDA Stock Rallies Alongside Analyst Updates After Q4 Beats

Feb 28, 2025

www.tipranks.com | Access denied (403) Current session has been terminated. For further information, do not hesitate to contact us. Ref:…

Read more
intentsify-named-a-leader-in-b2b-intent-data-analyst-report

Intentsify Named a Leader in B2B Intent Data Analyst Report

Feb 27, 2025

Intentsify top-ranked in Current Offering and received the highest possible scores in 12 criteria WESTWOOD, Mass., February 27,…

Read more
this-plumas-bancorp-analyst-begins-coverage-on-a-bullish-note;-here-are-top-4-initiations-for-thursday-–-compass-pathways-(nasdaq:cmps),-hasi-(nyse:hasi)

This Plumas Bancorp Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday – Compass Pathways (NASDAQ:CMPS), HASI (NYSE:HASI)

Feb 27, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more

Intentsify Named a Leader in B2B Intent Data Analyst Report

Feb 27, 2025

Intentsify, a global provider of B2B intent data and signal-based marketing solutions, has been named a Leader in…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 231
  6. 232
  7. 233
  8. 234
  9. 235
  10. 236
  11. 237
  12. ...
  13. 382
  14. »

Posts pagination

Newer posts Page 1 … Page 234 … Page 382 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.